Turenne Santu00e9 invests across the entire healthcare value chain, supporting both early-stage innovation through venture capital and profitable small-to-mid-cap healthcare companies through growth and buyout capital.
About Turenne Santé
Turenne Sante is the dedicated healthcare arm of France’s Turenne Capital, operating at turennecapital.com with a clear specialization signal in the fund name itself. While the structured input fields are unfilled, the platform is well established in French and broader European healthcare investing, typically focused on growth equity and expansion-stage positions in medtech, diagnostics, services, and specialty pharma rather than seed-stage software bets. For healthcare AI founders, this is a relevant target only if you are at Series B and beyond with meaningful revenue, operating in France or with a credible French market entry plan, and ready for a partner that values clinical evidence, reimbursement coverage, and regulatory clarity. The firm’s healthcare focus is a genuine asset: founders pitching here will engage with partners who understand HAS, EMA, and European hospital procurement rather than needing to educate them. Early-stage US digital health companies, AI infrastructure plays without clinical traction, and pre-revenue medtech are not the right fit. Check sizes for this kind of European mid-market healthcare fund typically span EUR 5M to EUR 30M with capacity for follow-on. Best entry path is a banker-led process or a warm introduction from a French healthcare ecosystem connector, supplemented by LinkedIn outreach to a partner with a focused one-pager covering revenue, clinical evidence, reimbursement status, and competitive moat. Founders should have French-language commercial materials ready and a clear thesis on European expansion before opening a serious conversation here.
Founder reviews
Other portfolio companies
Companies in Turenne Santé's portfolio not currently in our directory.
- DeepLife · 2024
- SamanTree Medical SA · 2024
- MIR u2013 Medical International Research · 2025
- VedaLab · 2025
- Domain Therapeutics · 2022
- H.A.C.Pharma · 2022
- Amolyt Pharma
- PhysioAssist
Team
Pitch / review this investor
Have you raised from Turenne Santé? Founders only — share your honest experience (anonymous OK, moderated before publishing).